Abstract
ObjectiveResolvins (RvD1, RvD2 and RvE1) are endogenous anti-inflammatory lipid mediators that display potent analgesic properties in somatic pain by modulating transient receptor potential vanilloid 1 (TRPV1) activation. To what extent...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have